Literature DB >> 33121349

Reply to letter from Alvarez et al.

Jesús Ruiz-Aragón1, Ray Gani2, Sergio Márquez3, Piedad Alvarez4.   

Abstract

Keywords:  Influenza; Quadrivalent influenza vaccine (QIV); Spain; burden of illness; cell-based vaccines; costeffectiveness; high-risk; vaccination

Year:  2020        PMID： 33121349      PMCID： PMC7996077          DOI： 10.1080/21645515.2020.1813485

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  8 in total

1.  Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018.

Authors:  Katia J Bruxvoort; Yi Luo; Bradley Ackerson; Hilary C Tanenbaum; Lina S Sy; Ashesh Gandhi; Hung Fu Tseng
Journal:  Vaccine       Date:  2019-08-22       Impact factor: 3.641

2.  Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.

Authors:  Hector S Izurieta; Yoganand Chillarige; Jeffrey Kelman; Yuqin Wei; Yun Lu; Wenjie Xu; Michael Lu; Douglas Pratt; Steve Chu; Michael Wernecke; Thomas MaCurdy; Richard Forshee
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

3.  Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.

Authors:  Laurie DeMarcus; Lisa Shoubaki; Susan Federinko
Journal:  Vaccine       Date:  2019-06-11       Impact factor: 3.641

4.  Estimating a cost-effectiveness threshold for the Spanish NHS.

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Pedro Serrano-Aguilar
Journal:  Health Econ       Date:  2017-12-28       Impact factor: 3.046

5.  Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain.

Authors:  Jesús Ruiz-Aragón; Ray Gani; Sergio Márquez; Piedad Alvarez
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

6.  Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018-2019.

Authors:  Hector S Izurieta; Yoganand Chillarige; Jeffrey Kelman; Yuqin Wei; Yun Lu; Wenjie Xu; Michael Lu; Douglas Pratt; Michael Wernecke; Thomas MaCurdy; Richard Forshee
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

7.  Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies.

Authors:  Vincenzo Restivo; Claudio Costantino; Stefania Bono; Marialuisa Maniglia; Valentina Marchese; Gianmarco Ventura; Alessandra Casuccio; Fabio Tramuto; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-06-16       Impact factor: 3.452

8.  Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018.

Authors:  Constantina Boikos; Gregg C Sylvester; John S Sampalis; James A Mansi
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.